Clinical Trials & Research

Print this page FOSTER CITY, Calif.–(BUSINESS WIRE)–May 7, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted regulatory approval of Veklury® (remdesivir) as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19, under an exceptional approval pathway. The exceptional approval was granted due to the COVID-19 pandemic and
0 Comments
A Keele University academic is part of a team of researchers who are calling for the World Health Organisation (WHO) to change its official definition of the weak bone condition osteoporosis in order to increase consistency of diagnosis internationally and to also increase the uptake of treatment. Dr Zoe Paskins, a Senior Lecturer and Consultant
0 Comments
Print this page NEW YORK & MAINZ, Germany–(BUSINESS WIRE) May 5, 2020 –Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development
0 Comments
Ben-Gurion University of the Negev (BGU) scientists have developed a new methodology to trace the SARS-CoV-2 virus through the sewage and wastewater systems, which could potentially be used to track existing and future outbreaks of the coronavirus. Environmental monitoring of sewage can be effective if clinical testing is deficient in ascertaining the infection rate. Sewage
0 Comments
Print this page FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 29, 2020– Gilead Sciences. Inc. (Nasdaq: GILD) is aware of positive data emerging from the National Institute of Allergy and Infectious Diseases’ (NIAID) study of the investigational antiviral remdesivir for the treatment of COVID-19. We understand that the trial has met its primary endpoint and that NIAID will provide detailed
0 Comments
Kudos, the award-winning service for accelerating research impact, has today announced that it is opening up its leading research communications platform – Kudos Pro – to the global academic community, with complimentary access for 60 days. Over 2,000 researchers around the world have already signed up for complimentary access following an exclusive pre-launch. With campuses
0 Comments
Print this page FOSTER CITY, Calif.–(BUSINESS WIRE)–May 1, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the investigational antiviral remdesivir to treat COVID-19. The EUA will facilitate broader use of remdesivir to treat hospitalized patients with severe COVID-19 disease, enabling access to remdesivir at
0 Comments
May 1 2020 Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections. Image Credits: royaltystockphoto.com / Shutterstock.com The new antibiotic — administered via the windpipe to target lung infections
0 Comments
Print this page FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 29, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and 10-day dosing durations of the investigational antiviral remdesivir in hospitalized patients with severe manifestations of COVID-19 disease. The study demonstrated that patients receiving a 10-day treatment course of remdesivir
0 Comments
Steady hands and uninterrupted, sharp vision are critical when performing surgery on delicate structures like the brain or hair-thin blood vessels. While surgical cameras have improved what surgeons see during operative procedures, the “steady hand” remains to be enhanced — new surgical technologies, including sophisticated surgeon-guided robotic hands, cannot prevent accidental injuries when operating close
0 Comments
Print this page DUBLIN and SOUTH SAN FRANCISCO, Calif., April 23, 2020 /PRNewswire/ – Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma” or the “Company”), a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, today announced that the first healthy volunteer has been dosed in a Phase 1 study of TD-0903. TD-0903 is a lung-selective, nebulized Janus
0 Comments
Print this page London, UK 23 April 2020 — GlaxoSmithKline plc today announced data from an updated analysis of the GARNET trial, which demonstrated that dostarlimab, an investigational anti-programmed death-1 (PD-1) monoclonal antibody, provided clinically meaningful results in women with recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer who progressed on or after a platinum-based
0 Comments
Reviewed by Emily Henderson, B.Sc.Apr 28 2020 Researchers at the Wyss Institute at Harvard University, in collaboration with healthcare, research, and industrial partners, have designed a new, fully injection-molded nasopharyngeal swab that can be manufactured quickly and inexpensively at high volume to help address the nationwide and international shortage of swabs for COVID-19 testing and
0 Comments
Print this page Paris and Tarrytown, N.Y. April 27, 2020 – Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the preliminary results from the Phase 2 portion of an ongoing Phase 2/3 trial evaluating Kevzara® (sarilumab), an interleukin-6 (IL-6) receptor antibody, in hospitalized patients with “severe” or “critical” respiratory illness caused by COVID-19. Following
0 Comments
Reviewed by Emily Henderson, B.Sc.Apr 28 2020 By leveraging the basics of artificial intelligence technology now used to predict risk for suicide or other mental health issues, researchers developed an AI system that analyzes linguistic patterns to predict a youth’s risk for committing acts of school violence. Study data published in the International Journal of
0 Comments
Researchers at the University of Louisville have discovered an application for their research in fighting the novel coronavirus responsible for the COVID-19 pandemic. Researcher Paula Bates, John Trent, and Don Miller developed a therapeutic drug that could potentially block the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the COVID-19 pandemic. Their research was
0 Comments
Older adults and those with underlying medical conditions are at risk of experiencing severe coronavirus disease (COVID-19). Younger people appeared to experience only mild illness, but doctors warn that the viral infection may cause sudden strokes. COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can cause sudden strokes in adults, between the
0 Comments
A new study shows the role that viral genomic sequencing can play in the current COVID-19 pandemic. The virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has spread rapidly across the globe, infecting over 2.6 million and killing over 183,000. The only intervention currently possible is in the form of non-pharmacological measures, chiefly contact
0 Comments
The demand for ventilators has dramatically increased over the past months, due to the coronavirus disease (COVID-19) pandemic. With the increasing number of infected people across the globe, health systems have become overwhelmed, and equipment shortage is a huge problem. Further, health workers are at a high risk of contracting the virus due to invasive
0 Comments
In a new study, Swedish researchers speculate the effects of the present intervention strategies on the healthcare system as the COVID-19 pandemic affects the nation. Their study titled, “Intervention strategies against COVID-19 and their estimated impact on Swedish healthcare capacity,” has not been published yet; however, the findings are available as pre-peer-reviewed study at medRxiv.
0 Comments
Reviewed by Emily Henderson, B.Sc.Apr 18 2020 Persistent inflammation of the pancreas (chronic pancreatitis) is a known risk factor for developing pancreatic cancer, the third-deadliest cancer in the United States. Tuft cells–cells sensitive to chemical (chemosensory) changes typically found in the intestines and respiratory tract–had previously been discovered in the pancreas, but their function has
0 Comments
Reviewed by Emily Henderson, B.Sc.Apr 17 2020 Federal officials offering emergency funding to hospitals, clinics and doctors’ practices have included this stipulation: They cannot foist surprise medical bills on COVID-19 patients. But buried in the Department of Health and Human Services’ terms and conditions for eligibility is language that could carry much broader implications. It
0 Comments